Defunct Company
Total Trials
18
As Lead Sponsor
4
As Collaborator
14
Total Enrollment
11,216
NCT02366234
Symptomatic Treatment of Distal Tubercle Fractures of the Scaphoid
Phase: N/A
Role: Collaborator
Start: Jan 31, 2015
Completion: Jan 31, 2016
NCT05693688
Atosiban Versus Placebo in the Treatment of Late Threatened Pre-term Birth
Phase: Phase 4
Start: Dec 1, 2017
Completion: Feb 29, 2024
NCT04707326
Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study
Start: Nov 1, 2019
Completion: Nov 1, 2026
NCT06083155
The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)
Start: Oct 15, 2020
Completion: Oct 31, 2035
NCT05851989
Study on Prognosis of Acutely Ruptured Intracranial Aneurysms
Role: Lead Sponsor
Start: Jul 14, 2021
Completion: Jul 14, 2034
NCT06130111
Spatial Location of Breast Cancer Local Recurrence After Mastectomy
Start: Sep 1, 2021
Completion: Jan 1, 2024
NCT06118723
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Start: Jan 1, 2022
Completion: Jan 1, 2028
NCT05346367
Improving Therapeutic Ratio With Hypo Fractionated Stereotactic Radiotherapy for Brain Metastases
Start: Jul 18, 2022
Completion: Mar 31, 2027
NCT05216328
Prevention of Opioid-induced Constipation in Patients With Advanced Cancer
Start: Dec 2, 2022
Completion: Dec 31, 2025
NCT06146725
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Start: Jan 1, 2023
Completion: Jan 1, 2029
NCT06146738
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
NCT06273176
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
NCT06283927
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
NCT05677269
The (Cost-)Effectiveness of Surgical Excision of Colorectal Endometriosis Compared to ART Treatment Trajectory
Start: Feb 17, 2023
NCT06204341
Towards Optimal Treatment for High Risk Prostate Cancer
Start: Jan 2, 2024
Completion: Dec 18, 2032
NCT05725512
Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages
Start: Jan 29, 2024
Completion: Jul 29, 2027
NCT06082492
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
Start: Mar 19, 2024
Completion: Jun 30, 2029
NCT06359782
Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH)
Phase: Phase 2
Start: Nov 4, 2024